These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Facial Seborrheic Dermatitis in HIV-Seropositive Patients: Evaluation of the Efficacy and Safety of a Non-Steroidal Cream Containing Piroctone Olamine, Biosaccharide Gum-2 and Stearyl Glycyrrhetinate - A Case Series. Cortés-Correa C; Piquero-Casals J; Chaparro-Reyes D; Garré Contreras A; Granger C; Peñaranda-Contreras E Clin Cosmet Investig Dermatol; 2022; 15():483-488. PubMed ID: 35330623 [TBL] [Abstract][Full Text] [Related]
4. A novel cosmetic antifungal/anti-inflammatory topical gel for the treatment of mild to moderate seborrheic dermatitis of the face: an open-label trial utilizing clinical evaluation and erythema-directed digital photography. Dall' Oglio F; Tedeschi A; Fusto CM; Lacarrubba F; Dinotta F; Micali G G Ital Dermatol Venereol; 2017 Oct; 152(5):436-440. PubMed ID: 28121079 [TBL] [Abstract][Full Text] [Related]
5. Exploring Anti-Fungal, Anti-Microbial and Anti-Inflammatory Properties of a Topical Non-Steroidal Barrier Cream in Face and Chest Seborrheic Dermatitis. Balato A; Caiazzo G; Di Caprio R; Scala E; Fabbrocini G; Granger C Dermatol Ther (Heidelb); 2020 Feb; 10(1):87-98. PubMed ID: 31705438 [TBL] [Abstract][Full Text] [Related]
6. Seborrheic dermatitis: an update. Bukvić Mokos Z; Kralj M; Basta-Juzbašić A; Lakoš Jukić I Acta Dermatovenerol Croat; 2012; 20(2):98-104. PubMed ID: 22726283 [TBL] [Abstract][Full Text] [Related]
7. Pimecrolimus 1% cream for the treatment of seborrheic dermatitis: a systematic review of randomized controlled trials. Ang-Tiu CU; Meghrajani CF; Maano CC Expert Rev Clin Pharmacol; 2012 Jan; 5(1):91-7. PubMed ID: 22142161 [TBL] [Abstract][Full Text] [Related]
8. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis. Warshaw EM; Wohlhuter RJ; Liu A; Zeller SA; Wenner RA; Bowers S; Schultz JC; Katz HI; McCormick CL; Parneix-Spake A J Am Acad Dermatol; 2007 Aug; 57(2):257-64. PubMed ID: 17188780 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of topical 4% Quassia amara gel in facial seborrheic dermatitis:a randomized, double-blind, comparative study. Diehl C; Ferrari A J Drugs Dermatol; 2013 Mar; 12(3):312-5. PubMed ID: 23545914 [TBL] [Abstract][Full Text] [Related]
10. Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: a randomized clinical study. Cicek D; Kandi B; Bakar S; Turgut D J Dermatolog Treat; 2009; 20(6):344-9. PubMed ID: 19954391 [TBL] [Abstract][Full Text] [Related]
11. Treatment of cradle cap in infants with a new cosmetic non-steroidal gel cream: Clinical, laboratory, and instrumental evaluation. Micali G; Pulvirenti N; Dall'Oglio F; Tedeschi A; Quattrocchi E; Lacarrubba F J Cosmet Dermatol; 2021 Apr; 20 Suppl 1(Suppl 1):14-17. PubMed ID: 33934474 [TBL] [Abstract][Full Text] [Related]
12. Topical pimecrolimus 1% cream for resistant seborrheic dermatitis of the face: an open-label study. Ozden MG; Tekin NS; Ilter N; Ankarali H Am J Clin Dermatol; 2010; 11(1):51-4. PubMed ID: 20000875 [TBL] [Abstract][Full Text] [Related]
13. An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face. Elewski B Clin Dermatol; 2009; 27(6 Suppl):S48-53. PubMed ID: 19878781 [TBL] [Abstract][Full Text] [Related]
14. Pimecrolimus: a new treatment for seborrheic dermatitis. Crutchfield CE Cutis; 2002 Oct; 70(4):207-8. PubMed ID: 12403310 [TBL] [Abstract][Full Text] [Related]
15. Clinical and instrumental evaluation of a new topical non-corticosteroid antifungal/anti-inflammatory/antiseborrheic combination cream for the treatment of mild-to-moderate facial seborrheic dermatitis. Dall'Oglio F; Lacarrubba F; Luca M; Boscaglia S; Granger C; Micali G Clin Cosmet Investig Dermatol; 2019; 12():103-108. PubMed ID: 30774406 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of terbinafine 1% cream on seborrhoeic dermatitis. Gündüz K; Inanir I; Sacar H J Dermatol; 2005 Jan; 32(1):22-5. PubMed ID: 15841656 [TBL] [Abstract][Full Text] [Related]
17. Topical Treatment of Facial Seborrheic Dermatitis: A Systematic Review. Gupta AK; Versteeg SG Am J Clin Dermatol; 2017 Apr; 18(2):193-213. PubMed ID: 27804089 [TBL] [Abstract][Full Text] [Related]
18. Treatment of facial seborrheic dermatitis with pimecrolimus cream 1%: an open-label clinical study in Korean patients. Kim BS; Kim SH; Kim MB; Oh CK; Jang HS; Kwon KS J Korean Med Sci; 2007 Oct; 22(5):868-72. PubMed ID: 17982237 [TBL] [Abstract][Full Text] [Related]
19. A pilot study on seborrheic dermatitis using pramiconazole as a potent oral anti-Malassezia agent. Piérard GE; Ausma J; Henry F; Vroome V; Wouters L; Borgers M; Cauwenbergh G; Piérard-Franchimont C Dermatology; 2007; 214(2):162-9. PubMed ID: 17341867 [TBL] [Abstract][Full Text] [Related]
20. Role of antifungal agents in the treatment of seborrheic dermatitis. Gupta AK; Nicol K; Batra R Am J Clin Dermatol; 2004; 5(6):417-22. PubMed ID: 15663338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]